We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares
NBP

80 hedge funds and large institutions have $1.13B invested in NovaBridge Biosciences American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 15 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,007% more call options, than puts

Call options by funds: $295K | Put options by funds: $14K

136% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 11

125% more funds holding in top 10

Funds holding in top 10: 4 → 9 (+5)

100% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 15

84% more capital invested

Capital invested by funds: $616M → $1.13B (+$515M)

23% more funds holding

Funds holding: 65 → 80 (+15)

6.04% more ownership

Funds ownership: 8.06% → 14.09% (+6%)

Holders
80
Holders Change
+15
Holders Change %
+23.08%
% of All Funds
1.4%
Holding in Top 10
9
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+125%
% of All Funds
0.16%
New
26
Increased
30
Reduced
15
Closed
11
Calls
$295K
Puts
$14K
Net Calls
+$281K
Net Calls Change
+$281K

Top Buyers

Rank Fund Capital Flow
1
HA
HHLR Advisors
Cayman Islands
+$278M
2
WA
WFM Asia
British Virgin Islands
+$56.3M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$37.4M
4
GCM
Ghisallo Capital Management
Massachusetts
+$22.8M
5
Bank of America
Bank of America
North Carolina
+$22.2M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$31.9M
2
APM
Avidity Partners Management
Texas
-$14.2M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$10.2M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$7.14M
5
CH
CVI Holdings
Delaware
-$7.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
26
Jennison Associates
New York
$8.25M +$9.24M +170,260 New
TCM
27
Tekla Capital Management
Massachusetts
$8.09M +$9.05M +166,896 New
BlackRock
28
BlackRock
New York
$7.75M +$701K +12,929 +9%
JCAM
29
Jericho Capital Asset Management
New York
$7.22M +$8.08M +149,000 New
Goldman Sachs
30
Goldman Sachs
New York
$7.2M +$7.19M +132,595 +828%
JP Morgan Chase
31
JP Morgan Chase
New York
$6.94M +$7.77M +143,211 +1,193,425%
Renaissance Technologies
32
Renaissance Technologies
New York
$5.05M -$1.97M -36,300 -26%
Lord, Abbett & Co
33
Lord, Abbett & Co
New Jersey
$4.62M +$1.39M +25,704 +37%
CCM
34
CAAS Capital Management
New York
$3.59M +$4.02M +74,029 New
SSA
35
Schonfeld Strategic Advisors
New York
$3.4M +$3.81M +70,251 New
WAM
36
WT Asset Management
Hong Kong
$2.69M +$3.01M +55,471 New
SFM
37
Sphera Funds Management
Israel
$2.66M -$6.88M -126,858 -70%
Marshall Wace
38
Marshall Wace
United Kingdom
$2.6M -$5.28M -97,289 -64%
QC
39
Quaero Capital
Switzerland
$2.35M +$2.63M +48,490 New
VIA
40
Vident Investment Advisory
Georgia
$2.34M -$228K -4,203 -8%
Qube Research & Technologies (QRT)
41
Qube Research & Technologies (QRT)
United Kingdom
$2.04M +$2.28M +42,099 New
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$1.83M +$2.05M +37,816 New
IBT
43
International Biotechnology Trust
United Kingdom
$1.69M +$1.9M +35,000 New
Fidelity Investments
44
Fidelity Investments
Massachusetts
$1.61M -$1.07M -19,710 -37%
CAM
45
CIF Asset Management
Hong Kong
$1.58M +$1.77M +32,649 New
Citigroup
46
Citigroup
New York
$1.55M +$599K +11,048 +53%
Norges Bank
47
Norges Bank
Norway
$1.45M – – –
BFM
48
Boothbay Fund Management
New York
$1.45M +$663K +12,223 +69%
Balyasny Asset Management
49
Balyasny Asset Management
Illinois
$1.25M +$1.4M +25,731 New
EMG
50
ETF Managers Group
New Jersey
$1.04M -$665K -12,249 -36%
1
2
3 4

NBP Hedge Fund Activity: Q1 2021 in Review

80 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2021, worth a combined $1.13B — up 84% from $616M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new NBP positions and 11 closed out — a net gain of 15 holders — while 30 added to existing stakes and 15 trimmed.

The largest buyer was HHLR Advisors, adding an estimated $278M. The largest seller was OrbiMed, cutting an estimated $31.9M.

  • 80 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2021, up from 65 in Q4 2020.
  • Funds reported $1.13B of NovaBridge Biosciences American Depositary Shares stock for Q1 2021, up 84% quarter-over-quarter.
  • 26 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2021 and 11 closed out, a net change of +15 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2021 was HHLR Advisors, an estimated $278M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2021 was OrbiMed, an estimated $31.9M sold.

Based on aggregated 13F filings for Q1 2021.